BEIJING, Nov. 4, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: CCM), an operator of specialty cancer hospitals and the largest network of radiotherapy and diagnostic imaging centers in China, today announced it will release its financial results for the third quarter of 2014 after the market closes on November 17, 2014.
Management will hold a conference call to discuss the results the following day, at 8:00 a.m. Eastern Time on November 18, 2014 (9:00 p.m. in Beijing/Hong Kong on November 18, 2014).
The dial-in details for the live conference call are as follows:
U.S. Toll Free: 1 866 519 4004
International: 65 67239381
U.K. Toll Free: 08082346646
Hong Kong Toll Free: 800-906-601
China Local: 400-620-8038 / 800-819-0121
Passcode: CCM
A replay of the conference call may be accessed by phone at the following numbers for 7 days:
U.S. Toll Free: 1 855 452 5696
International: 6 12 8199 0299
Conference ID: 30474533
Additionally, a live and archived webcast of the conference call will be available on the investor relations section of the Company's website at: http://ir.concordmedical.com/.
Concord Medical filed its annual report on Form 20-F for the fiscal year ended December 31, 2013 (the "2013 Annual Report") with the Securities and Exchange Commission (the "SEC") on April 28, 2014. The 2013 Annual Report can be accessed at the SEC's website at http://ww.sec.gov or the Company's investor relations website at http://ir.concordmedical.com. Concord Medical will provide a hard copy of the 2013 Annual Report containing its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.
About Concord Medical
Concord Medical Services Holdings Limited is an operator of specialty cancer hospitals and the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2014, the Company operated a network of 141 centers with 81 hospital partners that spanned 56 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.
For more information, please contact:
Mr. Adam J. Sun (Chinese and English)
+86-10-5957-5266
adam.sun@concordmedical.com
Mr. Ting Jia (Chinese and English)
+86-10-5957-5270
ting.jia@concordmedical.com
Ms. Fang Liu (Chinese and English)
+86-10-5903-6688 (ext. 639)
fang.liu@concordmedical.com
ICR Inc.
In China:
Ms. Rene Jiang
+86-10-6583-7521
rene.jiang@icrinc.com
In the United States:
Mr. William Zima
+1-203-682-8233
William.Zima@icrinc.com
SOURCE Concord Medical Services Holdings Limited
